McCourt Marion

CIK 00016637585 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001663758

Recent Transactions

50 trades

Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-12-09$701.51/sh−1,021→ 14,349 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-12-08$712.94/sh−1,336→ 15,370 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2025-12-05+12,210→ 12,210 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2025-12-05+2,476→ 16,706 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-12-16$730.81/sh−759→ 14,230 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-12-09$787.00/sh−274→ 14,989 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-12-06+2,332→ 15,263 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-12-06+8,981→ 8,981 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-11-01$381.40/sh+1,000→ 13,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-11-01−1,000→ 6,000 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-11-01$844.61/sh−1,000→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-10-01$381.40/sh+1,000→ 13,931 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-10-01$1054.06/sh−1,000→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-10-01−1,000→ 7,000 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-09-03−1,000→ 8,000 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-09-03$381.40/sh+1,000→ 13,931 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-09-03$1178.73/sh−1,000→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-08-01−1,137→ 0 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-01$1060.86/sh−1,137→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-08-01$372.46/sh+1,137→ 14,068 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-07-01$1047.11/sh−1,137→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-07-01−1,137→ 1,137 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-07-01$372.46/sh+1,137→ 14,068 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-03$980.16/sh−1,138→ 12,931 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2024-06-03−1,138→ 2,274 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-06-03$372.46/sh+1,138→ 14,069 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-05-01$889.41/sh−250→ 12,931 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-04-01$964.73/sh−250→ 13,181 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-03-01$967.50/sh−358→ 13,431 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-05$934.71/sh−1,000→ 13,789 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-02-01$945.61/sh−273→ 14,789 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2024-01-02$873.91/sh−274→ 15,062 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-12$856.71/sh−5,105→ 15,336 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-11$838.44/sh−270→ 20,814 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-11$844.09/sh−373→ 20,441 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-08+2,133→ 21,084 total
Award
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-12-08+7,649→ 7,649 total
Tax Payment
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-12-08$843.79/sh−852→ 18,951 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-11-01$783.91/sh−1,000→ 19,803 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-11-01$381.40/sh+1,000→ 20,803 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-11-01−1,000→ 9,000 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-10-02$372.46/sh+1,038→ 20,841 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-10-02−1,038→ 3,412 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-10-02$827.00/sh−1,038→ 19,803 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-09-01$834.55/sh−250→ 19,803 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-08-01$744.66/sh−250→ 20,053 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-07-03$710.09/sh−250→ 20,303 total
Sale
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-06-01$736.00/sh−250→ 20,553 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Common Stock
2023-04-03$372.46/sh+1,100→ 21,903 total
Exercise/Conversion
REGENERON PHARMACEUTICALS, INC.$REGN
Non-Qualified Stock Option (right to buy)
2023-04-03−1,100→ 4,450 total

Companies

Recent Filings

Address

C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR

SAN FRANCISCO, CA, 94105

View on SEC.gov